RecruitingPHASE1, PHASE2NCT03211793

Mesenchymal Stromal Cells as Treatment for Digital Ulcers in Systemic Sclerosis

Studying Diffuse cutaneous systemic sclerosis

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
UMC Utrecht
Principal Investigator
Marianne Verhaar, MD, PhD
UMC Utrecht
Intervention
Mesenchymal stromal cells(drug)
Enrollment
20 enrolled
Eligibility
18 years · All sexes
Timeline
2021 – 2026

Study locations (1)

Collaborators

ZonMw: The Netherlands Organisation for Health Research and Development

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03211793 on ClinicalTrials.gov

Other trials for Diffuse cutaneous systemic sclerosis

Additional recruiting or active studies for the same condition.

See all trials for Diffuse cutaneous systemic sclerosis →

← Back to all trials